← SynDRA
GW9508
SynDRA canonical compound SYN0006170 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | FFAR4 |
|---|
| Mechanism of action | G protein-coupled receptor agonist |
|---|
All known targets
Mechanisms of action (all sources)
- Free fatty acid receptor agonist
- G protein-coupled receptor agonist
- FFAR1 PARTIAL AGONIST
- FFAR4 PARTIAL AGONIST
- FFAR4 AGONIST
- FFAR1 AGONIST
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- PPARG
- PTGER4
- PPARA
- PPARD
- PTGER1
- PTGER3
- HCAR2
- S1PR1
- SMUG1
- TDG
- KDM4A
- TDP1
- UNG
- OGG1
- NTHL1
- NEIL2
- NEIL1
- MUTYH
- MPG
- MBD4
- ADGRF1
- HDAC6
- ADRA2A
- GPR35
- ADRB2
- AGTR1
- APEX1
- APLNR
- C5AR1
- CX3CR1
- CYP1A2
- CYP2C19
- CYP2C9
- CYP2D6
- CYP3A4
- FFAR2
- FFAR3
- FPR2
- GLP1R
- GMNN
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Cross-references
Synonyms
- GW 9508
- GW-9508
- 4T77GYP2CS
- Benzenepropanoic acid, 4-(((3-phenoxyphenyl)methyl)amino)-
- Benzenepropanoic acid, 4-[[(3-phenoxyphenyl)methyl]amino]-
- RefChem:783292
- 3-(4-((3-Phenoxybenzyl)amino)phenyl)propanoic acid
- 3-(4-{[(3-phenoxyphenyl)methyl]amino}phenyl)propanoic acid
- 3-[4-[(3-phenoxyphenyl)methylamino]phenyl]propanoic Acid
- 3-(4-(3-phenoxybenzylamino)phenyl)propanoic acid
- MFCD09753282
- 4-[[(3-Phenoxyphenyl)methyl]amino]benzenepropanoic acid
- SMR000486399
- GPR40 Agonist
- UNII-4T77GYP2CS
- carboxylic acid agonist, 2
- MLS001065626
- MLS006010293
- SCHEMBL364468
- GTPL1050
- orb1307459
- SCHEMBL29766936
- BDBM22496
- CHEBI:93259
- EX-A223
- GLXC-05204
- HMS2197G09
- HMS3261P03
- HMS3269J09
- HMS3355B18
- HMS3413N13
- HMS3650I20
- HMS3653H19
- HMS3677N13
- HMS3748O03
- KKB10189
- Tox21_500551
- AKOS016002280
- CCG-221855
Look up GW9508 in the interactive SynDRA portal →